Investigating long-term effects of severe lung disease in children
Official title: Long Term Outcome of Severe Lung Disease in Childhood
Run by Odense University Hospital · NCT06455800 · Data updated 2026-11-12
This study looks at how severe lung disease affects children over time to help doctors better understand and manage their health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Day to 18 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Odense) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | December 31, 2039 |
| Study ends | December 31, 2039 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT06455800 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 0-18 years diagnosed with severe lung disease.
✕Probably not a fit
Patients who do not provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to understand the long-term consequences of severe lung disease in children by registering patients aged 0-18 years at the HCA Children's Hospital. It will collect data on various parameters, including height, weight, lung function test results, and imaging diagnostics, during yearly follow-ups. The study seeks to identify prognostic markers that can predict outcomes for children with severe lung disease, thereby enhancing monitoring and management strategies.
Why it matters
Potential benefit: If successful, this study could improve the understanding of lung disease prognosis in children, leading to better management and treatment strategies.
How similar studies have gone: While there is limited information on similar studies, the approach of investigating prognostic markers in pediatric lung diseases is valuable and has potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: severe lung disease - Exclusion Criteria: no informed consent \-
Where it's running
-
Hans Christian Andersen Children's Hospital
Odense, Denmark Recruiting
Study contacts
- Principal investigator: Josefine Gradman, PhD — Odense University Hospital
- Study coordinator: Josefine Gradman, PhD
- Email: josefine.gradman@rsyd.dk
- Phone: 0045 29241375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Singing training versus usual care after lung cancer surgery (6–18 months post-operation)
This trial will test whether an online singing program can help people who had surgery for early-stage non-small cell lung cancer 6–18 months ago feel better, breathe easier, and improve physical fitness.
-
Virtual reality-assisted dual-task training to boost muscle oxygenation in COPD
We will test whether virtual reality-assisted exercises that combine thinking and moving can improve muscle oxygen levels in people with moderate COPD (GOLD stage 2-3).
-
Using small mobile stem cells to treat chronic obstructive pulmonary disease.
This study is testing if inhaling small mobile stem cells is safe for people with mild to moderate COPD.
-
Investigating the role of estrogen in lung disease
This study is testing how changes in estrogen levels affect lung health in women with asthma and COPD, especially during menopause, to see if lower estrogen makes their lung function worse.
-
Personalized music feedback to improve walking for people with COPD
This study is testing whether a mobile app that uses personalized music can help people with COPD stick to their walking exercises and feel less tired while doing them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.